Wolverine Trading
TCRT icon

Wolverine Trading’s Alaunos Therapeutics TCRT Stock Holding History

Wolverine Trading’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-179
Closed -$13.2K – 5101
2023
Q2 		$13.2K Buy
179
+72
+67% +$5.83K ﹤0.01% 4125
2023
Q1 		$11K Buy
+107
New +$10.2K ﹤0.01% 4069
2022
Q4 		– Sell
-410
Closed -$122K – 5011
2022
Q3 		$122K Buy
410
+298
+266% +$86.6K ﹤0.01% 3839
2022
Q2 		$21K Buy
112
+35
+45% +$3.35K ﹤0.01% 4231
2022
Q1 		$8K Sell
77
-13
-14% -$1.67K ﹤0.01% 5302
2021
Q4 		$15K Buy
+90
New +$19.8K ﹤0.01% 5525
2021
Q3 		– Sell
-111
Closed -$45K – 6939
2021
Q2 		$45K Sell
111
-15
-12% -$7K ﹤0.01% 5616
2021
Q1 		$64K Sell
126
-60
-32% -$37.4K ﹤0.01% 5594
2020
Q4 		$74K Sell
186
-15
-7% -$5.96K ﹤0.01% 4543
2020
Q3 		$78K Sell
201
-55
-21% -$24.3K ﹤0.01% 4189
2020
Q2 		$123K Sell
256
-179
-41% -$79.8K ﹤0.01% 4064
2020
Q1 		$166K Sell
435
-135
-24% -$69.9K ﹤0.01% 3783
2019
Q4 		$410K Sell
570
-24
-4% -$16.5K ﹤0.01% 3254
2019
Q3 		$376K Sell
594
-67
-10% -$53.1K ﹤0.01% 2932
2019
Q2 		$578K Buy
661
+156
+31% +$107K ﹤0.01% 2566
2019
Q1 		$291K Sell
505
-428
-46% -$179K ﹤0.01% 3392
2018
Q4 		$232K Buy
+933
New +$369K ﹤0.01% 3534
2018
Q3 		– Sell
-779
Closed -$458K – 5856
2018
Q2 		$458K Hold
779
– – ﹤0.01% 3194
2018
Q1 		$458K Buy
779
+146
+23% +$91K ﹤0.01% 3194
2017
Q4 		$393K Buy
633
+132
+26% +$94.8K ﹤0.01% 3275
2017
Q3 		$461K Buy
+501
New +$445K ﹤0.01% 2705
2017
Q2 		– Sell
-961
Closed -$930K – 4947
2017
Q1 		$930K Sell
961
-46
-5% -$42.8K 0.01% 1778
2016
Q4 		$808K Sell
1,007
-143
-12% -$129K ﹤0.01% 2127
2016
Q3 		$963K Buy
1,150
+35
+3% +$28.1K ﹤0.01% 1895
2016
Q2 		$965K Buy
+1,115
New +$1.21M 0.01% 1621

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCA
Magnolia Capital Advisors Jackson, Mississippi $509M AUM 18.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Wolverine Trading's TCRT Position: Q3 2023 in Review

Wolverine Trading sold out of Alaunos Therapeutics (TCRT) in Q3 2023, closing a stake of 158 shares — an estimated $6.81K sold.

Wolverine Trading first reported a position in TCRT in Q2 2016 and held it in 23 quarters. The position peaked at $557K in Q2 2019. 89 funds tracked by Wall St. Rank hold TCRT as of Q3 2023.

  • Wolverine Trading reported no remaining Alaunos Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Wolverine Trading sold 158 Alaunos Therapeutics shares in Q3 2023, an estimated $6.81K.
  • Wolverine Trading first reported a position in Alaunos Therapeutics in Q2 2016 and held it in 23 quarters.
  • Wolverine Trading's Alaunos Therapeutics position peaked at $557K in Q2 2019.
  • 89 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2023.

Based on Wolverine Trading's 13F filing for Q3 2023, filed 15 Nov 2023.